Standard vs Atrial Fibrillation spEcific managemenT studY

Not Applicable

Completed

• Conditions: Atrial Fibrillation; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12610000221055
• Lead Sponsor: Baker IDI Heart & Diabetes Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 335

Inclusion Criteria

1. Documented diagnosis of sustained form of non-valvular atrial fibrillation
2. A minimum of one hospitalisation (including index admission) related, at least in part, to atrial fibrillation
3. Are living independently in the community or their own home post-hospitalisation
4. Are able and willing to provide written informed consent to participate in the trial

Exclusion Criteria

1. Aged below 45 years
2. Have a diagnosis of valvular atrial fibrillation
3. Are scheduled for a catheter ablation for treatment of atrial fibrillation
4. Have evidence of pre-existing New York Heart Association (NYHA) Class III-IV with a documented left ventricular ejection fraction less than 45%
5. Have alcohol-induced atrial fibrillation
6. Have transient forms of atrial fibrillation associated with acute myocardial infarction and/or pericarditis
7. Have a terminal condition or malignancy requiring palliative care
8. Cannot adequately provide written informed consent to participate
9. Have any other medical condition that results in the belief that it is not appropriate for the patient to embark on participation within this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified